logo
Sweet dreams? Not if you eat this popular snack before bed, study says

Sweet dreams? Not if you eat this popular snack before bed, study says

Yahoo01-07-2025
Looking for a gouda night of sleep? You might want to steer clear of this little nibble before bed.
A new study in the journal Frontiers in Psychology suggests dairy might be the grate-est villain to sweet dreams.
Researchers polled 1,000 students at MacEwan University in Canada on their sleep quality and eating habits and found an un-brie-lievable link between nightmares and lactose intolerance.
'Nightmare severity is robustly associated with lactose intolerance and other food allergies,' said lead study author Tore Nielsen of Université de Montréal.
'These new findings imply that changing eating habits for people with some food sensitivities could alleviate nightmares. They could also explain why people so often blame dairy for bad dreams!'
Looks like that delectable cube of cheese could have you waking up in a cold, curdled sweat!
Unsurprisingly, this is especially true if you're sensitive to dairy — which many people unknowingly are.
'Nightmares are worse for lactose-intolerant people who suffer severe gastrointestinal symptoms and whose sleep is disrupted,' said Nielsen.
'This makes sense, because we know that other bodily sensations can affect dreaming.'
Nightmares can rob people of restful sleep, Nielsen noted, because they tend to cause the dreamer to awaken in a state of distress — and they may lead to sleep avoidance.
About one-third of the study participants admitted that they regularly experience nightmares, with women significantly more likely to remember their dreams and report food allergies than men.
Around 40% believed late-night snacking or eating certain foods could lead to tossing and turning all night. Most blamed sweets, spicy food and dairy for their nighttime woes.
Only 5.5% of participants suspected what they snacked on seeped into their dreams, but of those, dairy reigned supreme as the dream-warping devil.
Still, more research is needed before we give up on cheese Roquefort-ever.
'We need to study more people of different ages, from different walks of life, and with different dietary habits to determine if our results are truly generalizable to the larger population,' said Nielsen.
'Experimental studies are also needed to determine if people can truly detect the effects of specific foods on dreams. We would like to run a study in which we ask people to ingest cheese products versus some control food before sleep to see if this alters their sleep or dreams.'
That's nacho average study!
The findings shed insight into folklore wisdom that goes back as far as 'A Christmas Carol,' in which Ebenezer Scrooge famously blamed 'a crumb of cheese' for his ghostly visions.
In 2005, the British Cheese Board — a cultured organization, to be sure — conducted a study with 200 people and found no link between cheese and nightmares.
In fact, a hunk of cheddar appeared to lead to more pleasant dreams, possibly because a happy belly equals a placid midnight mind.
And a recent study found cheese might even prevent sleep apnea, thanks to its nutritional density.
So — why does cheese keep getting grilled?
Some cheeses contain tyramine, a compound that can stimulate the brain by triggering the release of norepinephrine, a chemical that can make you feel more alert.
However, biomedical scientist Dr. Zac Turner recently pointed out that most people only eat a few cubes of cheese in one sitting, which would deliver negligible amounts of tyramine.
He noted that if you're pairing your cheeseboard with a bottle of wine, that's more likely to be the culprit, as alcohol is a known disruptor of sleep.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New emergency shelter to be built in central industrial area of Saskatoon
New emergency shelter to be built in central industrial area of Saskatoon

Yahoo

timean hour ago

  • Yahoo

New emergency shelter to be built in central industrial area of Saskatoon

The City of Saskatoon has announced the location for an enhanced emergency shelter will be on 31st Street E., just off Idylwyld Drive. The site is currently a parking lot for Saskatchewan Polytechnic, which is relocating its campus to Innovation Place. The shelter will have about 60 beds and operate 24 hours a day, seven days a week, the city said in a news release. Clients will receive three meals a day, case planning and supports. A timeline for construction and an opening date have not been set yet. Neighbourhood information sessions are being planned for next month. The permanent location will replace the temporary shelter that opened in April 2025 on Pacific Avenue, in the city's downtown, which is only supposed to be open for 18 months. The number of homeless people in Saskatoon has been increasing. A point-in-time count on Oct. 8, 2024, identified 1,499 people experiencing homelessness, nearly three times higher than the previous count in 2022, which identified 550. The city is working on developing a Saskatoon Homelessness Action Plan, which passed the committee stage last month and is expected to be considered for approval this fall. The provincial government will lead the design and construction of the new facility on 31st Street E. and fund ongoing operations. The shelter will be operated by The Mustard Seed, a Christian non-profit organization.

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

Yahoo

time3 hours ago

  • Yahoo

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

LAVAL, QC / / August 15, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and managed funds have increased their ownership of the Company's common shares. The increase reflects the acquisition by Paulson Capital Inc. and certain affiliates and managed funds of the net long position of 34,721,118 common shares previously held by Mr. Carl C. Icahn and his affiliates (collectively, "Icahn Group"). The Company is not a party to any agreement or arrangement with Paulson Capital Inc. or its affiliates or the Icahn Group in connection with these transactions. Based on information provided to the Company, Paulson Capital Inc. and certain affiliates and managed funds beneficially owns approximately 19.13% of the Company's outstanding common shares as of the date hereof. The Company further announced that the Director Appointment and Nomination Agreement, dated as of February 23, 2021, between the Company and Icahn Group, terminated pursuant to its terms when the Icahn Group's net long position in the Company's shares fell below the specified threshold. In connection with the termination, Brett M. Icahn and Steven D. Miller have resigned from the Board of Directors (the "Board"). "I believe there is significant value in Bausch Health and am confident in the Company's efforts to maximize shareholder value. I am excited about the underlying business prospects in both Bausch Health and its subsidiary, Bausch + Lomb Corporation," John A. Paulson, Chairperson of the Bausch Health Board, said. "I also want to thank Brett and Steven for their dedication and valuable contributions to the Company." About Bausch Health Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit and connect with us on LinkedIn. Forward-looking Statements This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@ (877) 281-6642 (toll free) (908) 569-3692 SOURCE: Bausch Health Companies Inc. View the original press release on ACCESS Newswire Sign in to access your portfolio

Opinion: Closing Alberta harm-reduction hubs is going backwards
Opinion: Closing Alberta harm-reduction hubs is going backwards

Yahoo

time3 hours ago

  • Yahoo

Opinion: Closing Alberta harm-reduction hubs is going backwards

In 2018, a middle-aged man arrived on my patient panel. I will call him Jon. Jon was being treated in our clinic for hepatitis C but did not yet have his own family physician. When I met with him for our first visit, he told me the story of how he had contracted, years prior while incarcerated, this chronic viral infection of the liver. Supplies for tattoos and drug use were contraband at the time, so he and other inmates had shared needles and syringes. By the mid-1990s, studies were advancing our understanding of harm reduction. Based on growing scientific evidence, Canada began to implement programs that were known then as needle exchanges and have since evolved into low-barrier, wraparound services. Many today think of harm reduction as being about drug use only — supervised consumption sites for example. But harm reduction is nothing new. It was historically integral to the HIV/AIDS movement of the late 1980s and early '90s, when communities of men who have sex with men and people who use drugs (PWUD) demanded access to care that helped them reduce their risk of disease transmission. It worked. Today's modern care includes a whole spectrum of public health interventions that sharply decrease the risk of sexually transmitted and blood-borne infections (STBBI). These include things as simple as access to condoms or new syringes. The gold standard is to provide these on demand. Anything less, like having to exchange your used syringe for a new one, increases infections. In Alberta, harm-reduction services are often co-located with primary health care, including pregnancy and wound care as well as treatment for substance use and other mental health disorders. These centres are resource hubs for people who find themselves in the most painful of life's trying moments. Red Deer's Turning Point Society, founded in 1988 in response to the HIV/AIDS epidemic, is the only resource of this kind in all of central Alberta. This week, it was announced that all provincial funding for Turning Point will be discontinued on Nov. 1. What will closures like this mean for Albertans? Without access to wraparound services that include best harm-reduction practices, blood-borne and sexually transmitted infections including hepatitis, HIV, gonorrhea, chlamydia and syphilis will rise. Hospital use and costs will also increase due to more skin, organ and bone infections, more ICU stays, and even amputations. The cost of infections like these is a high price to pay compared to a harm-reduction kit that costs around a dollar. There is a common conception that the neighbourhoods around resource hubs such as Turning Point are more likely to have many discarded needles and syringes or that they are 'honeypots' for drug dealers. Studies have shown these not to occur. In fact, the hubs' cleanup and outreach crews often ensure that the area is more tidy and safer than they would be otherwise. My patient Jon came a long way since I first met him in 2018. He was eventually cured of his hepatitis C. He continued to use injection drugs and was careful to never share equipment — he knew the risks. He relied on our centre — one of Calgary's resource hubs — not only for his drug use supplies but also for getting tested regularly for STBBIs, screened for chronic diseases as he aged, and mental health supports. We have all, in fact, come a long way since the days before harm reduction. Watching, from Calgary, the defunding of central Alberta's resource hub, I fear for other similar centres — places like Alpha House in Calgary and George Spady in Edmonton. What is to become of the places that have always, as the evidence guides, provided low-barrier, wraparound care? That are doing what studies show is safest, healthiest, and most cost-effective. They have not only their clients' and patients' best interests in mind, but also the public's. By shuttering low-barrier and harm-reduction services, we are going backwards, not forwards. As citizens, we must object to the UCP's misguided and regressive restructuring and fight for places like Turning Point, Alpha House, and George Spady. History and science have shown that these are the places doing the work that helps us all. Dr. Bonnie Larson is a clinical assistant professor of family medicine at the University of Calgary. Letters welcome We invite you to write letters to the editor. A maximum of 150 words is preferred. Letters must carry a first and last name, or two initials and a last name, and include an address and daytime telephone number. All letters are subject to editing. We don't publish letters addressed to others or sent to other publications. Email: letters@ Bookmark our website and support our journalism: Don't miss the news you need to know — add and to your bookmarks and sign up for our newsletters here. You can also support our journalism by becoming a digital subscriber. Subscribers gain unlimited access to The Edmonton Journal, Edmonton Sun, National Post and 13 other Canadian news sites. Support us by subscribing today: The Edmonton Journal |The Edmonton Sun.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store